Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2018-03-05 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2018
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28 February 2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update. The document is lengthy (15,000 characters) and contains detailed data on share capital changes, not just an announcement or summary. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2018-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2018
Capital/Financing Update Classification · 95% confidence The document is a detailed monthly report on movements in securities for a listed issuer, including authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related movements. It is addressed to the Hong Kong Exchanges and Clearing Limited and covers the month ended 31 January 2018. The content focuses on share capital changes, share options, warrants, and convertible securities, which are typical elements of capital structure updates. There is no indication of financial performance data, earnings, management discussion, or legal proceedings. The document is not a report publication announcement or a certification but a substantive report on capital movements. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-02-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2017
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 December 2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, management commentary, or voting results. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update. The document is lengthy (15,000 characters) and contains detailed data on share capital changes, not just an announcement or a brief summary. Therefore, it fits best under Capital/Financing Update (CAP).
2018-01-03 English
ANNOUNCEMENT CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Regulatory Filings Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding a change of the company's principal place of business in Hong Kong. It is a short announcement (1648 characters) and does not contain any financial data, management discussion, or detailed report content. It is not a report itself but an operational update. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2017-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2017
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly report on movements in securities for Uni-Bio Science Group Limited, including authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related movements. It is addressed to the Hong Kong Exchanges and Clearing Limited and covers the month ended 30 November 2017. The content focuses on share capital changes, share options, and related securities movements rather than financial performance, earnings, or management commentary. It is not an announcement of a report but a substantive regulatory filing detailing capital changes. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2017-12-01 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the grant of share options to directors of Uni-Bio Science Group Limited. It references compliance with Listing Rules and details the number of options granted, exercise price, vesting period, and names of directors receiving the options. The content is about share option grants, which is a capital-related event but not a full financial report or earnings release. The document length is short (3165 characters) and it is an announcement rather than a detailed report. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes such as share options.
2017-11-16 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.